Role of Cost-Sharing Subsidies on the Initiation of and Adherence to Tyrosine Kinase Inhibitor Therapy by Medicare Beneficiaries With Chronic Myeloid Leukemia. Article uri icon

Overview

publication date

  • February 13, 2017

Research

keywords

  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Identity

Scopus Document Identifier

  • 85021856253

Digital Object Identifier (DOI)

  • 10.1200/JCO.2016.72.0011

PubMed ID

  • 28524780

Additional Document Info

volume

  • 35

issue

  • 15